Details of the Drug
General Information of Drug (ID: DMMVL5P)
| Drug Name |
3,6,9,12,15-PENTAOXATRICOSAN-1-OL
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
3,6,9,12,15-Pentaoxatricosan-1-ol; n-Octylpentaoxyethylene; 19327-40-3; PENTAETHYLENE GLYCOL MONOOCTYL ETHER; Pentaoxyethylene monooctyl ether; polyoxyethylene 5 octyl ether; C;Pentaethyleneglycolmonooctylether; 2-[2-[2-[2-(2-octoxyethoxy)ethoxy]ethoxy]ethoxy]ethanol; Octylpentaglycol; N8E; C18H38O6; AC1L4MMQ; SCHEMBL61744; C8E5; Octyl pentaethylene glycol ether; DTXSID6075192; CTK0H9802; Pentaethylene glycol, octyl ether; MJELOWOAIAAUJT-UHFFFAOYSA-N; AC1Q5919; ZINC16051619; 7571AH; MFCD00043032; AKOS027320404; DB08249; LS-102023
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 350.5 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 21 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 6 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


